My Companies
Notification
Account
Log Out
Back

Krebs Biochemicals Board Approves Merger With Ipca Laboratories In All-Stock Deal

26 June 2026
Krebs Biochemicals & Industries Ltd.

Board approved Scheme of Amalgamation with Ipca Laboratories Limited. Exchange ratio of 7 shares of Ipca (Re.1) for every 200 shares of Krebs (Rs.10). Appointed date April 1, 2026, subject to regulatory approvals.

Recent Events

No recent events

No events have occurred recently

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information